Houlihan Lokey Advises Enclara Healthcare

Houlihan Lokey is pleased to announce that the firm successfully advised Consonance Capital Partners on its sale of certain assets of Enclara Healthcare to Humana Inc. (NYSE:HUM). Assets acquired by Humana include Enclara Pharmacia, Guidant Rx, and Avanti Health Care Services. The transaction closed on January 31, 2020.

Founded in 1996 and headquartered in Philadelphia, Pennsylvania, Enclara Healthcare is one of the nation’s largest hospice pharmacy and benefit management providers, serving more than 450 hospice providers and 97,000 hospice patients per day through multiple, scalable models designed to fit unique customer needs. The company is a leading solutions provider focused on simplifying care delivery in chronic and complex care patient populations to improve patient experience, quality, and cost. Enclara drives value-based care in collaboration with healthcare organizations through expertise, process, and technology.

Consonance Capital Partners invests in private companies in the lower middle market of the U.S. healthcare industry with an emphasis on businesses driving efficiency, cost containment, and high-quality clinical care to patients. Consonance Capital Partners participates in growth equity, leveraged buyout, and recapitalization transactions.

This transaction further strengthens Houlihan Lokey’s leadership position in the pharmacy sector, becoming its sixth closed M&A transaction in this space since 2016. Houlihan Lokey's Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2019, the group was ranked the No. 1 M&A advisor for all U.S. healthcare transactions by Refinitiv (formerly known as Thomson Reuters).

RELATED: Healthcare, Capital Markets